Company Overview - West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services, supporting both established and emerging drug developers [4] - The company has over 10,000 team members across 50 sites, including 25 manufacturing facilities worldwide, delivering over 41 billion components and devices each year [4] Financial Performance - In fiscal year 2024, West generated $2.89 billion in net sales [5] - The company is traded on the New York Stock Exchange (NYSE: WST) and is included in the Standard & Poor's 500 index [5] Upcoming Events - West will release its first-quarter financial results before the market opens on April 24, 2025, followed by a conference call at 9:00 a.m. Eastern Time [1] - A slide presentation will be available on the company's website on the day of the call, and a replay of the conference call and webcast will be accessible for approximately 90 days after the event [3]
West to Host First-Quarter 2025 Conference Call